◀ Back to JUN

ESR2 — JUN

Text-mined interactions from Literome

Planas-Silva et al., Cancer Res 1999 (Breast Neoplasms) : Other transcriptional cofactors that allow estrogen receptor to induce expression of AP-1 may be required for estrogen to act as a mitogen
Wu et al., Eur J Endocrinol 2000 : The results suggest that, during gestation, myometrial ERbeta may inhibit AP-1 activity and thus block induction of the cx43 gene and other labor associated genes
Petz et al., Endocrinology 2002 (Breast Neoplasms) : Purified estrogen receptor ( ER ) enhanced binding of Fos and Jun to the +90 AP-1 site and bound to an adjacent imperfect ERE half-site
Kanda et al., J Invest Dermatol 2003 : Transfection of ERbeta enhanced the inhibitory effects of E2 on Sp1 and AP-1 transcriptional activities and MCP-1 promoter activities in nontransfected keratinocytes ... These results suggest that E2-bound ERbeta may inhibit MCP-1 gene expression by inhibiting Sp1 and AP-1 transcriptional activities in keratinocytes
Tonetti et al., J Steroid Biochem Mol Biol 2003 (Breast Neoplasms) : Furthermore, ERbeta , at least in the context of the MDA-MB-231 cellular milieu, does not enhance AP-1 activity in the presence of antiestrogens
Schmitt et al., J Neurosci Res 1995 : Using transient transfections in neuroblastoma NE-1-115 and COS-1 cells, we show that ligand activated estrogen receptor ( HEGo ) represses the transcriptional activation by c-Fos/c-Jun